Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial ; volume:13 ; number:6 ; year:2020 ; pages:572-583
Obesity facts ; 13, Heft 6 (2020), 572-583
- Urheber
-
Tronieri, Jena S.
Fabricatore, Anthony N.
Wadden, Thomas A.
Auerbach, Pernille
Endahl, Lars
Sugimoto, Danny
Rubino, Domenica
- DOI
-
10.1159/000511130
- URN
-
urn:nbn:de:101:1-2020122323343483789047
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tronieri, Jena S.
- Fabricatore, Anthony N.
- Wadden, Thomas A.
- Auerbach, Pernille
- Endahl, Lars
- Sugimoto, Danny
- Rubino, Domenica
Ähnliche Objekte (12)
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial